Over the course of TB treatment, we observed as a general trend that cellular subsets within CM CD4+ and TEMRA CD8+ populations increased, whereas naïve CD4+ and naïve/EM CD8+ subsets decreased. The gene discussed is CD4; the disease is tuberculosis.